维普中文期刊产品整合服务
13篇 您的检索式:作者名="Engstrom JM"
    题名 作者 年代 出处 被引量
1NCCN Clinical Practice Guidelines in Oncology:rectal cancer 显示文摘Engstrom PF Arnoletti JP Benson AB 3rd Chen YJ Choti MA Cooper HS Covey A Dilawari RA Early DS Enzinger PC Fakih MG Fleshman J Jr Fuchs C Greta JL Kiel K Knol JA Leong LA Lin E Mulcahy MF Rao S Ryan DP Saltz L Shibata D Skibber JM Sofocleous C Thomas J Venook AP Willett C 2009J Natl Compr Canc Netw2009,7,:1
2A pilot study to determine the safety and feasibility of oropharyngeal administration of own mother's colostrum to extremely low-birth-weight infants显示文摘Rodriguez NA Meier PP Groer MW Zeller JM Engstrom JL Fogg L 2010Adv Neonatal Care2010,10,4:1
3Templated open fiocs of nanorods for enhanced pulmonary delivery with pressurized metered dose inhalers显示文摘Engstrom JD Tam JM Miller MA 0,,01:1
4Templated open flocs of anisotropic particles for pulmonary delivery with pressurized metered dose inhalers显示文摘Tam JM Engstrom JD Ferrer D 0,,07:1
5Fipamezole (JP-1730) Is a Potent Alpha2 Adrenergic Receptor Antagonist that Reduces Levodopa-induced Dyskinesia in the MPTP-lesioned Primate Model of Parkinson's Disease显示文摘SAVOLA JM HILL M ENGSTROM M 2003Mov Disord (S0885-3185)2003,18,8:1
6Fipamezole(JP-1730)is a potent alpha 2 adrenergic receptor antagonist that reduces levodopa-indnced dyskinesia in the MPTP-lesioned primate model of Parkinson's disease显示文摘Savola JM Hill M Engstrom M 2003Mov Disord2003,18,8:1
7Fipamezole ( JP- 1730) is a potent alpha2 adrenergic receptor antagonist that reduces levodopa-induced dyskinesia in the MPTP-lesioned primate model of Parkinson's disease 显示文摘SAVOLA JM HILL M ENGSTROM M 2003Mov Disord2003,18,8:1
8A randomized con- trolled trial of the oropharyngeal administration of mother's colostrum to extremely low birth weight infants in the first days of life显示文摘Rodriguez NA Zeller JM Engstrom JL 2011Neonat Int Care2011,24,4:1
9Templated open floes of nanorods for enhanced pulmonary delivery with pressurized metered dose inhalers 显示文摘Engstrom JD Tam JM Miller MA 2009Pharm Res2009,26,1:1
10Fipamezole ( JP-1730 ) is a potent alpha 2 adrenergic receptor antagonist that reduces levodopa-induced dyskinesia in the MPTP-lesioned primate model of Parkinson's disease显示文摘Savola JM HillM Engstrom M 2003Mov Disord2003,18,8:1
11Fipamezole(JP- 1730)is a potent alpha 2 adrennergic receptor antagonist that reduces lovodopa-in-duced dyskinesia in the MPTP-lesioned primate model of Pakinson's disease显示文摘Savola JM Hill M Engstrom M 2003Mov Disord2003,18,8:1
12Breastfeeding peerc- Counselors as direct lactation care providers in the neonatal intensive care unit显示文摘Meier PP Engstrom JM Rossman B 2013J Hum Lact2013,29,3:1
13Fipamezole (JP-1730) is a potent alpha2 adrenergic receptor antagonist that reduces levodopa-induced dyskinesia in the MPTP-lesioned primate model of Parkinson's disease显示文摘Savola JM Hill M Engstrom M 2003Mov Disord2003,18,8:1
返回顶部 每页显示:
共1页 首页 上一页 第1页 下一页 末页 /1 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费